Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10168546rdf:typepubmed:Citationlld:pubmed
pubmed-article:10168546lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10168546lifeskim:mentionsumls-concept:C0010403lld:lifeskim
pubmed-article:10168546lifeskim:mentionsumls-concept:C0005791lld:lifeskim
pubmed-article:10168546lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:10168546lifeskim:mentionsumls-concept:C0205430lld:lifeskim
pubmed-article:10168546lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:10168546pubmed:issue4lld:pubmed
pubmed-article:10168546pubmed:dateCreated1997-8-19lld:pubmed
pubmed-article:10168546pubmed:abstractTextThirty-four patients affected by mixed cryoglobulinaemia have been submitted to treatment by apheresis (plasma exchange or double cascade filtration). The authors have monitored clinical, laboratory and, above all, haemorheological changes following therapy. The final results have shown mainly a reduction of plasma viscosity and consequently an improvement of the haemorheology of the affected organs. In conclusion, apheresis may be considered a successful therapy in patients with severe renal or neurological diseases due to mixed cryoglobulinaemia.lld:pubmed
pubmed-article:10168546pubmed:languageenglld:pubmed
pubmed-article:10168546pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10168546pubmed:citationSubsetTlld:pubmed
pubmed-article:10168546pubmed:statusMEDLINElld:pubmed
pubmed-article:10168546pubmed:monthDeclld:pubmed
pubmed-article:10168546pubmed:issn0955-3886lld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:ManniniLLlld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:AvanziGGlld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:GiustiSSlld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:RussoG EGElld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:VanniniFFlld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:PennacchiaMMlld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:VitalianoEElld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:CaramielloM...lld:pubmed
pubmed-article:10168546pubmed:authorpubmed-author:De MarcoC MCMlld:pubmed
pubmed-article:10168546pubmed:issnTypePrintlld:pubmed
pubmed-article:10168546pubmed:volume17lld:pubmed
pubmed-article:10168546pubmed:ownerNLMlld:pubmed
pubmed-article:10168546pubmed:authorsCompleteYlld:pubmed
pubmed-article:10168546pubmed:pagination499-503lld:pubmed
pubmed-article:10168546pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10168546pubmed:meshHeadingpubmed-meshheading:10168546...lld:pubmed
pubmed-article:10168546pubmed:meshHeadingpubmed-meshheading:10168546...lld:pubmed
pubmed-article:10168546pubmed:meshHeadingpubmed-meshheading:10168546...lld:pubmed
pubmed-article:10168546pubmed:meshHeadingpubmed-meshheading:10168546...lld:pubmed
pubmed-article:10168546pubmed:meshHeadingpubmed-meshheading:10168546...lld:pubmed
pubmed-article:10168546pubmed:meshHeadingpubmed-meshheading:10168546...lld:pubmed
pubmed-article:10168546pubmed:year1996lld:pubmed
pubmed-article:10168546pubmed:articleTitleHaemorheological changes in mixed cryoglobulinaemia during apheresis treatment.lld:pubmed
pubmed-article:10168546pubmed:affiliationPlasmapheresis and Dialysis Unit, Institute of 1 Clinical Medica, University of Rome, La Sanienza, Italy.lld:pubmed
pubmed-article:10168546pubmed:publicationTypeJournal Articlelld:pubmed